Top Markets
#1 Pearl Pearl +3.30%
#2 Wiki Cat Wiki Cat +2.98%
#3 Fractal Bitcoin Fractal Bitcoin +2.15%
#4 WYDE: End Hunger WYDE: End Hunger +2.14%
#5 The Innovation Game The Innovation Game +2.10%
#6 Ocean Protocol Ocean Protocol +1.81%
#7 Useless Coin Useless Coin +1.61%
#8 Akedo Akedo +1.58%
#9 World Mobile Token World Mobile Token +1.45%
#10 DogBull DogBull +1.44%
Coin of the day
Pearl Pearl
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rangering i aksjer #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Aksjekurs
$0.88012714
Markedsverdi
$439.58M
Endring (1 dag)
-4.01%
Endring (1 år)
1,130.75%
Land
FR
Handel Valerio Therapeutics S.A. (ALVIO)

Kategori

Healthcare
Antall utestående aksjer for Valerio Therapeutics S.A. (ALVIO)
Antall utestående aksjer per September 2026: 0
Ifølge Valerio Therapeutics S.A. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av September 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Valerio Therapeutics S.A. (ALVIO) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH